Brief: Resverlogix Says Intends To Pursue U.S. Listing
31/07/2018 22:38
July 31 (Reuters) - Resverlogix Corp RVX.TO :
* RESVERLOGIX INTENDS TO PURSUE U.S. LISTING
* RESVERLOGIX - INTENDS TO REQUEST SHAREHOLDER APPROVAL FOR
CONSOLIDATION OF CO'S COMMON SHARES AT ANNUAL & SPECIAL MEETING
OF SHAREHOLDERS OF CO
* RESVERLOGIX CORP - COMPANY'S COMMON SHARES AND WARRANTS
WOULD
CONTINUE TO BE LISTED ON TORONTO STOCK EXCHANGE
Source text for Eikon: ID:nGNX9yMY6L
Further company coverage: RVX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resverlogix
See all newsBrief: Resverlogix Confirms Focus On Treatment Of Post Covid-19 Conditions
Brief: Resverlogix Announces New Research Findings Highlighting Safety Of BD2-Selective BET Inhibitors
Brief: Resverlogix Announces Type C Meeting With FDA For Coral, A Phase 3 High-Risk Covid-19 Outpatient Study
Brief: Resverlogix Expands Phase 2B Clinical Trial For Covid-19 Treatment With First Site In Brazil And Second In Canada
Brief: Resverlogix Announces Commencement Of Patient Enrollment And Dosing In A Phase 2B Trial For COVID-19 Treatment